Debevoise & Plimpton LLP secured an important win at the New York Court of Appeals on behalf of client Andrew Kolchins in his compensation dispute with...
Kolchins v. Evolution Markets, Inc.
Luitpold Pharmaceuticals, Inc. v. Pharmacosmos A/S
Baker Botts L.L.P. achieved wins at the United States Court of Appeals for the Federal Circuit (Federal Circuit) on behalf of firm client, Denmark-based, specialty pharmaceutical...
Percipient.ai’s $15 Million Round Funding
Cooley advised Venrock on leading Percipient.ai’s recent $14.7 million Series A funding round. As part of the transaction, Beim will join Percipient.ai’s board. Based in Silicon...
Pfizer’s Global Headquarters Relocation in NYC
Stroock represented pharmaceutical leader Pfizer Inc. as the anchor tenant in a recently signed 20-year office lease for its new global headquarters in the Hudson Yards...
Unchained Labs’s Acquisition of rap.ID
Cooley advised Unchained Labs on its acquisition of rap.ID, a leading provider of systems used for particle identification in biopharmaceutical development and quality control, as well...
American Securities’ acquisition of Prince International Corporation
Paul, Weiss, Rifkind, Wharton & Garrison, Von Wobeser y Sierra, Kirkland & Ellis and Creel, García-Cuéllar, Aiza y Enríquez advised on the deal The parent company...
Blackstone’s $1.8B Financing for The Spiral
Fried Frank acted as counsel to Blackstone Mortgage Trust, Inc. (NYSE: BXMT) in connection with its US$1.8 billion financing for Tishman Speyer’s construction of The Spiral,...
BlueLinx’s Acquisition of Cedar Creek
Fried Frank acted as counsel to BlueLinx (NYSE: BXC), in connection with the financing related to its acquisition of Cedar Creek, a leading building products wholesale...
Dyal Capital Partners’ Investmet in Vector Capital
Kirkland & Ellis LLP served as legal counsel to Vector. Fried, Frank, Harris, Shriver & Jacobson LLP served as legal counsel to Dyal. Vector Capital, a...
J.B. Poindexter & Co.’s $350 Million High?Yield Senior Notes Offering
Cravath represented the initial purchasers, led by J.P. Morgan Securities, in connection with the $350 million 144A/Reg. S high?yield senior notes offering of J.B. Poindexter &...
Livongo Health’s $105 million Series E Financing
Sidley represented Livongo Health on the transaction Livongo Health, the leading consumer digital health company empowering people with chronic conditions to live better and healthier lives,...
Novartis AG’s $8.7 Billion Acquisition of AveXis, Inc.
AveXis’ financial advisors are Goldman Sachs & Co. LLC and Centerview Partners LLC, and Cravath, Swaine and Moore LLP and Cooley LLP are acting as legal...